EZH1 and cancer: Although our data suggest that the nuclear p85β-USP7-EZH1/2 pathway is activated in cancer cells with a PIK3CA helical domain mutation, we cannot rule out the possibility that this pathway could also be triggered by certain physiological stimuli in normal cells as well.